Collegium Pharmaceutical, Inc. announced that effective May 24, 2024, Joe Ciaffoni will step down as President of the Company. Mr. Ciaffoni will serve as a member of the Board of Directors of the Company until the upcoming 2024 Annual Meeting of Shareholders and will not stand for re-election at the meeting. To ensure a seamless transition, Michael Heffernan, founder, former CEO and Chairman of the Board will serve as Interim President until a new CEO is appointed by the Board of Directors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
32.15 USD | +1.04% | +0.85% | +4.45% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.45% | 1.05B | |
+52.93% | 803B | |
+40.98% | 629B | |
-7.08% | 351B | |
+17.40% | 324B | |
+10.58% | 303B | |
+16.42% | 244B | |
+2.17% | 226B | |
+10.66% | 215B | |
+6.24% | 164B |
- Stock Market
- Equities
- COLL Stock
- News Collegium Pharmaceutical, Inc.
- Collegium Announces President and Board Changes